Course Information
MMI/Pfizer Workshop: Molecules to Medicines - How Biopharma Delivers
Date(s): Wednesday 23 November
Main Venue:
Molecular Medicine Ireland
Online Application Period: apply at education@molecularmedicineireland.ie
| Read a report of this year's Molecules to Medicines Course and Workshop here |
This MMI/Pfizer 1-day workshop, for 24 participants, comprises discussion of key issues arising during biopharmaceutical discovery, development, and manufacturing. It will include breakout group discussion of specially devised problem sets.
Course/Workshop Developers:
Senior Staff from Pfizer (please see at the bottom of this page)
Comments from participants on a previous run of the Workshop:"Extremely insightful, would recommend people to go to the workshop in addition to the lectures as it was more helpful to understand the speakers role within the Biopharma Company" "Really good. Problems force you to really think about how it works" |
| Programme - Wednesday 23 November |
 |
| 1000 | Introduction to the workshop: key issues in discovery, development, and manufacturing | ||
| 1015 | Tea/Coffee | ||
| DISCOVERY | |||
| 1035 | Issues in discovery: defining the breakout session problem set | ||
| 1105 | Breakout session 1: issues in discovery | ||
| 1145 | Breakout session 1 feedback | ||
| 1225 | Lunch break (lunch will be provided) | ||
| DEVELOPMENT | |||
| 1310 | Issues in development: defining the breakout session problem set | ||
| 1340 | Breakout session 2: issues in development | ||
| 1420 | Breakout session 2 feedback | ||
| 1500 | Coffee/Tea | ||
| MANUFACTURING | |||
| 1520 | Issues in manufacturing: defining the breakout session problem set | ||
| 1550 | Breakout session 3: issues in manufacturing | ||
| 1630 | Breakout session 3 feedback | ||
| 1710 | Discussion: key learnings | ||
|
Download the workshop schedule here |
|||
| Back to top | |||
Workshop Instructors
Workshop Instructors comprise key personnel from Pfizer
Dr Brian Fennell (Global Biotherapeutic Technologies, Pfizer)
Dr Patrick Gammell (Senior Process Development Scientist, Pfizer Grange Castle)
Dr Matthew Lambert (Global Biotherapeutic Technologies, Pfizer)
Dr Caroline Maher (Senior Scientist, Bio-Manufacturing Sciences Group, Pfizer Ireland Pharmaceuticals)
The Molecules to Medicines Course and Workshop were originally developed by:
Dr Davinder Gill (Assistant Vice President, Biologic Therapeutics, Pfizer, Cambridge, MA, USA)
Dr Brendan Hughes (Director of Development, Pfizer, Grange Castle)
Dr Mark Leonard (Director, Gene Expression Technologies, Pfizer BioPharma Campus, Andover, MA, USA)
Tour of Pfizer Grange Castle Facility
 |
 |
|
Following on from the MMI/Pfizer Molecules to Medicines-How Biopharma delivers Lecture Course (22 November) and Workshop (23 November), we are delighted to organise a free visit to the Pfizer Grange Castle Facilities, Dublin 22, on Thursday 24 November.
Participants will travel by bus from a meeting point in the city centre to Pfizer Grange Castle (and back). The visit will take place in the afternoon (time to be confirmed), and will cover:
- a facility video presentation
- a facility tour
- a round table discussion with course instructor(s)
Should you be interested, please let us know when applying for the workshop (please see below).
In the first instance this workshop is open to postgraduate students with research experience (e.g. at least one year into their PhD studies). If places are available we will open attendance to postdoctoral staff also. If you are interested in attending this workshop please send an email indicating your interest to education@MolecularMedicineIreland.ie after you have applied online for the lecture course. Please also indicate whether you wish to attend the Pfizer Grange Castle Facility Tour.
Attendance at the lecture course on the preceding day (Tu 22 Nov 2011) is compulsory - details are here.
Please note that you must first apply for the lecture course (Please see under ''Applications open'' on the forthcoming course page). Then apply separately for this workshop (See above)
